Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
124.00    1.50 (1.22%)
Bid:
123.00
Ask:
125.00
Spread: 2.00 (1.626%)
Market Cap: £74.60m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Share Incentive Plan

13 Mar 2014 07:00

RNS Number : 1866C
Intercede Group PLC
13 March 2014
 

Intercede Group plc

 

("Intercede" or the "Company")

 

Share Incentive Plan

 

 

Further to the announcement dated 13 January 2014, the Company confirms that it has established a HMRC approved SIP for all UK employees. The Board has agreed to make awards to all UK employees on the following basis:

 

1) Free Shares up to a value of £3,000 to be issued at the prevailing middle market price at the close of business the day before an award;

2) Partnership Shares to be subscribed for by employees either on a monthly or lump sum basis to a cumulative value of up to £1,800 to be purchased on market at the prevailing market price; and

3) Matching Shares which are to be given to employees on the basis of two Matching shares for each Partnership Share.

 

It is intended that Free Share and Matching Share awards will be met by the transfer of ordinary shares of 1p each ("Ordinary shares") currently held in Treasury and from continued on market purchases either by the Company or Capita IRG Trustees Limited as Trustee of the SIP. To the extent that Ordinary Shares are not available in Treasury or in the volume required through the market, it is the Company's intention to issue new Ordinary Shares to meet these awards.

 

As part of the SIP, Richard Parris (Chairman & CEO), Andrew Walker (Finance Director) and Jayne Murphy (Operations Director) will receive an initial Free Share award to the value of £3,000 on 26 March 2014. In addition, all three parties have made binding commitments to subscribe for £1,800 of Partnership Shares from the April 2014 payroll at the prevailing market price on that date. Their updated interests in the shares of the Company will be notified immediately following these transactions.

 

 

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558111

Andrew Walker, Finance Director

FinnCap

Tel. + 44 (0)20 7220 0500

Stuart Andrews, Corporate Finance

Joanna Weaving, Corporate Broking

 

About Intercede

Intercede is a software company specialising in identity and credential management with a global team of experts located in the US and UK.

Intercede's MyID software enables organisations to create and use trusted digital identities for employees, citizens and machines. This allows secure access to services, facilities, information and networks.

MyID meets the highest government standards yet is simple enough to be deployed onto consumer devices such as smart phones and tablets. Critically, MyID provides an easy, convenient and secure alternative to passwords.

Millions of identities are managed using MyID and Intercede has provided identity verification and management services to global customers for more than 20 years. MyID is a commercial off the shelf software product, designed and developed to be configurable so it can be embedded as the cornerstone of cyber security infrastructure for governments and corporations.

Customers trusting Intercede for secure digital identity include the US and UK governments and some of the world's largest corporations, telecommunications providers and information technology partners.

For more information about Intercede, please visit intercede.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAEDAFALLEAF
Date   Source Headline
10th Mar 200910:21 amRNSAdditional Listing
5th Feb 20097:00 amRNSPositive Trading Update
12th Jan 20097:00 amRNSContract with BT for NHS Nat'l Data Spine
8th Jan 20097:00 amRNSIntercede Technology Used by Queensland Police
15th Dec 20089:45 amRNSDirector's Share Purchase
15th Dec 20087:00 amRNSNew Contract with Lockheed Martin
9th Dec 20087:00 amRNSInterim Results
4th Dec 20087:00 amRNSNew Contracts
25th Nov 20087:00 amRNSNew Reseller Agreement
17th Nov 20087:00 amRNSNew Reseller Partnership
22nd Oct 20087:00 amRNSRe: US Maritime Credentialing Program
6th Oct 20087:00 amRNSStatement Re ActivIdentity Patent Claim
6th Oct 20087:00 amRNSPositive Trading Update
29th Sep 20087:00 amRNSSubcontract With Lockheed Martin
17th Sep 200810:37 amRNSDirector/PDMR Shareholding
27th Aug 200810:26 amRNSDirector/PDMR Shareholding
20th Aug 20087:00 amRNSAppointment of Global Sales D
25th Jul 20087:00 amRNSDirector/PDMR Shareholding
24th Jul 20087:00 amRNSTrading Update
30th May 20087:00 amRNSTotal Voting Rights
20th May 20087:00 amRNSFinal Results
14th May 20087:00 amRNSAdditional Listing
2nd May 200810:33 amRNSResponse to Press Speculation
11th Apr 20087:00 amRNSTrading Update
14th Feb 20087:00 amRNSTrading Update
17th Dec 200711:58 amRNSDirector Share Dealings
11th Dec 20077:01 amRNSInterim Results
3rd Oct 20077:00 amRNSTrading Update
6th Sep 20077:01 amRNSFurther Re Licence
30th Aug 20077:01 amRNSNew Licence Agreement
16th Aug 200710:01 amRNSAIM Rule 26
31st May 20077:00 amRNSTotal Voting Rights
25th May 20077:02 amRNSFinal Results
16th May 20077:01 amRNSPlacing
19th Apr 20075:25 pmRNSHolding(s) in Company
27th Mar 20077:02 amRNSTrading Update
19th Dec 200611:33 amRNSFurther US Government Win
18th Dec 20061:18 pmRNSDirector/PDMR Shareholding
14th Dec 20067:01 amRNSInterim Results
8th Dec 200611:43 amRNSTotal Voting Rights
27th Nov 20067:31 amRNSRe Gemalto Partnership in US
23rd Nov 200611:16 amRNSFurther US Government Wins
20th Nov 20067:02 amRNSNew US Government Contracts
16th Nov 20067:03 amRNSNew US Government Contract
23rd Oct 20067:01 amRNSContract Update
9th Oct 20067:01 amRNSUS Government Contract Win
1st Jun 20067:01 amRNSPreliminary Results
31st Mar 200612:00 pmRNSDirectorate Change
31st Mar 20067:02 amRNSTrading Statement
26th Jan 200610:38 amRNSFurther re OEM Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.